| Literature DB >> 30376607 |
Justin A Shapiro1, John J Varga2, Derek Parsonage3, William Walton4, Matthew R Redinbo4, Larry J Ross5, E Lucile White5, Robert Bostwick5, William M Wuest1,6, Al Claiborne3, Joanna B Goldberg2,6.
Abstract
Antibiotics with novel mechanisms of action are desperately needed to combat the increasing rates of multidrug-resistant infections. Bacterial pantothenate kinase (PanK) has emerged as a target of interest to cut off the biosynthesis of coenzyme A. Herein we report the results of an in vitro high-throughput screen of over 10 000 small molecules against Bacillus anthracis PanK, as well as a follow-up screen of hits against PanK isolated from Pseudomonas aeruginosa and Burkholderia cenocepacia. Nine hits are structurally categorized and analyzed to set the stage for future drug development.Entities:
Keywords: Bacillus; Pseudomonas; antibiotic resistance; high-throughput screening; pantothenate kinase
Mesh:
Substances:
Year: 2018 PMID: 30376607 PMCID: PMC6456334 DOI: 10.1002/cmdc.201800652
Source DB: PubMed Journal: ChemMedChem ISSN: 1860-7179 Impact factor: 3.466